
3 Business Models That Could Bring Million-Dollar Cures to Everyone
The Harvard Business Review website noted that product classes with fundamentally new performance profiles can’t be dropped into an existing business model and expected to work. The business model — how value is created, captured, and delivered — needs to be reinvented to support the new proposition. It’s unlikely that there will be a one-size-fits-all
Comments Off on 3 Business Models That Could Bring Million-Dollar Cures to Everyone • Read this story »
More Articles

Monopoly v. Openness: 2 Sides of IP Coin in the Pharmaceutical Industry
The SSRN website posted an article which noted that the pharmaceutical industry extensively relies on the patent system. It actively lobbies for the strengthening of the patent protection of its medical products. The results of its efforts may be found in bilateral and multilateral agreements. However,
Comments Off on Monopoly v. Openness: 2 Sides of IP Coin in the Pharmaceutical Industry • Read this story »